KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Net Cash Flow: 2010-2024

Historic Net Cash Flow for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $1.2 million.

  • TherapeuticsMD's Net Cash Flow rose 1507.04% to $999,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 216.12%. This contributed to the annual value of $1.2 million for FY2024, which is 105.87% up from last year.
  • As of FY2024, TherapeuticsMD's Net Cash Flow stood at $1.2 million, which was up 105.87% from -$19.9 million recorded in FY2023.
  • Over the past 5 years, TherapeuticsMD's Net Cash Flow peaked at $72.2 million during FY2021, and registered a low of -$226.2 million during FY2022.
  • Its 3-year average for Net Cash Flow is -$81.7 million, with a median of -$19.9 million in 2023.
  • Its Net Cash Flow has fluctuated over the past 5 years, first slumped by 10,161.05% in 2020, then surged by 189.86% in 2021.
  • Yearly analysis of 5 years shows TherapeuticsMD's Net Cash Flow stood at -$80.3 million in 2020, then spiked by 189.86% to $72.2 million in 2021, then plummeted by 413.32% to -$226.2 million in 2022, then skyrocketed by 91.19% to -$19.9 million in 2023, then surged by 105.87% to $1.2 million in 2024.